Air Products and Chemicals (APD) came out with quarterly earnings of $2.86 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.82 per share a year ago.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Air Products and Chemicals (APD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Air Products and Chemicals (APD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Activist investor Mantle Ridge has secured enough support from Air Products and Chemicals investors to win several seats on the industrial gases company's board of directors, two people familiar with the matter said on Wednesday.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Preliminary adjusted EPS exceeds the upper end of APD's previous fiscal first-quarter guidance.
Air Products and Chemicals (APD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?
While the softness in China is a concern, APD benefits from its investments in high-return industrial gas projects and productivity actions.
Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DD and EMN are poised to navigate the industry challenges.
It's been a great year for the broader indexes, but recent market volatility may have some investors wondering if now is a good time to sell stocks.
Evercore ISI raised the firm's price target on Air Products to $375 from $365 and keeps an Outperform rating on the shares as a new analyst took over coverage of the stock and 10 other chemical names. Dissonance between sputtering industrial demand into year-end and prospects for a "less bad" 2025 has "muddled the forward outlook for chemicals investors" and the firm's sense is further EBITDA and EPS cuts coming to Q1 and FY25 "are needed to clear the deck," the analyst says. However, Evercore suspects the stocks "move sharply higher with signs of improving demand, so begin to position accordingly," the analyst added.